BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers

Abu Salim Mustafa

doi:10.3390/vaccines8040736

BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers

Vaccines (Basel). 2020 Dec 4;8(4):736. doi: 10.3390/vaccines8040736.

Author

Abu Salim Mustafa¹

Affiliation

¹ Department of Microbiology, Faculty of Medicine, Kuwait University, Safat 13110, Kuwait.

Abstract

Bacillus Calmette-Guérin (BCG) has been widely used globally as a prophylactic vaccine to protect against tuberculosis (TB) for about a century [...].

Publication types

Editorial